Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for Tough-to-Treat lung cancer

NCT ID NCT05882734

Ongoing Disease control Sponsor: EMD Serono Research & Development Institute, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new two-drug combination for people with a specific type of advanced lung cancer that has gotten worse after standard treatments. The goal is to see if the combination can shrink tumors and control the cancer. Researchers will also closely monitor the safety and side effects of the treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Aichi Cancer Center Hospital

    Nagoya, Japan

  • Asan Medical Center

    Seoul, South Korea

  • Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS - U.O. Oncologia Medica

    Bologna, Italy

  • CHU Angers - Hôpital Larrey - Service de Pneumologie

    Angers, France

  • CHU Limoges - Hôpital Dupuytren - Unite d'Oncologie Thoracique et Cutanée

    Limoges, France

  • CHU de Liège - PARENT

    Liège, Belgium

  • Cancer Institute Hospital of JFCR

    Kōtoku, Japan

  • Centre Hospitalier Intercommunal de Créteil - Service de Pneumologie

    Créteil, France

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica

    Rome, Italy

  • Groupe Hospitalier Sud - Hôpital Haut-Lévêque - Unité d'Explorations Fonctionnelles Respiratoires

    Pessac, France

  • Hopital Arnaud de Villeneuve - Service de Pneumologie-Addictologie

    Montpellier, France

  • Hospital Clinic de Barcelona - Servicio de Oncologia

    Barcelona, Spain

  • Hospital General Universitario Gregorio Marañon - Servicio de Oncologia Medica

    Madrid, Spain

  • Hospital Regional Universitario de Malaga - Oncology Dept

    Málaga, Spain

  • Hospital Universitari Vall d'Hebron - Oncology Dept.

    Barcelona, Spain

  • Hospital Universitari i Politecnic La Fe - Oncology Department

    Valencia, Spain

  • Hospital Universitario 12 de Octubre - Servicio de Oncologia

    Madrid, Spain

  • Hospital Universitario HM Madrid Sanchinarro - Servicio de Oncologia

    Madrid, Spain

  • Hospital Universitario La Paz - Oncology Department

    Madrid, Spain

  • Hospital Universitario Nuestra Señora de Valme - Servicio de Oncologia

    Seville, Spain

  • Hospital Universitario Ramon y Cajal - Servicio de Oncologia

    Madrid, Spain

  • Hospital Universitario Reina Sofia - Dept of Oncology

    Córdoba, Spain

  • Hospital Universitario Virgen Macarena - Oncology Service

    Seville, Spain

  • Hospital Universitario Virgen del Rocio - Oncology Service

    Seville, Spain

  • Hôpital de la Timone - CPCEM CIC - Bat F 1er étage

    Marseille, France

  • ICO - Site René Gauducheau - Service d'Oncologie medicale

    Saint-Herblain, France

  • IEO Istituto Europeo di Oncologia - Divisione Oncologia Medica

    Milan, Italy

  • Institut Jules Bordet - Department of Institut Jules Bordet'

    Anderlecht, Belgium

  • Istituto Clinico Humanitas - U.O. di Oncologia Medica ed Ematologia

    Rozzano, Italy

  • Istituto Nazionale Tumori Fondazione G. Pascale - Medical Oncology Thoraco-Pulmonary Department

    Naples, Italy

  • Istituto Nazionale Tumori Regina Elena IRCCS - S.C. Oncologia Medica B

    Roma, Italy

  • Jessa Ziekenhuis Hospital

    Hasselt, Belgium

  • Kanagawa Cancer Center

    Yokohama, Japan

  • Kansai Medical University Hospital

    Hirakata-shi, Japan

  • Kindai University Hospital

    Osakasayama-shi, Japan

  • Kurume University Hospital

    Kurume-shi, Japan

  • Millennium Research & Clinical Development

    Houston, Texas, 77090, United States

  • National Cancer Center Hospital

    Chūōku, Japan

  • National Cancer Center Hospital East

    Kashiwa-shi, Japan

  • Ospedale San Raffaele - U.O. di Oncologia Medica

    Milan, Italy

  • Samsung Medical Center

    Seoul, South Korea

  • Sana Klinikum Offenbach GmbH - Medizinische Klinik IV

    Offenbach, Germany

  • Severance Hospital, Yonsei University Health System - Division of Infectious Diseases

    Seoul, South Korea

  • Tennessee Cancer Specialists - Biomedical Research

    Knoxville, Tennessee, 37909, United States

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    Seoul, South Korea

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • UCLA Hematology and Oncology - Santa Monica

    Santa Monica, California, 90404, United States

  • UPMC Cancer Center

    Pittsburgh, Pennsylvania, 15232, United States

  • UZ Leuven

    Leuven, Belgium

  • UZA - Oncology

    Edegem, Belgium

  • Universitaetsklinikum Giessen und Marburg GmbH - Medizinische Klinik und Poliklinik III

    Giessen, Germany

  • Universitaetsklinikum Leipzig AoeR - Med. Klinik u. Poliklinik I - Abt. Pneumologie

    Leipzig, Germany

  • Universitair Ziekenhuis Brussel - UZB

    Jette, Belgium

  • Virginia Cancer Specialists, PC

    Fairfax, Virginia, 22031, United States

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER